paper-with-me

홈 › Papers

TxAgent: An AI Agent for Therapeutic Reasoning Across a Universe of Tools

2025-03-14 · ShangHua Gao, Richard Zhu, Zhenglun Kong, Ayush Noori, Xiaorui Su, Curtis Ginder, Theodoros Tsiligkaridis, Marinka Zitnik

Precision therapeutics require multimodal adaptive models that generate personalized treatment recommendations. We introduce TxAgent, an AI agent that leverages multi-step reasoning and real-time biomedical knowledge retrieval across a toolbox of 211 tools to analyze drug interactions, contraindications, and patient-specific treatment strategies. TxAgent evaluates how drugs interact at molecular, pharmacokinetic, and clinical levels, identifies contraindications based on patient comorbidities and concurrent medications, and tailors treatment strategies to individual patient characteristics. It retrieves and synthesizes evidence from multiple biomedical sources, assesses interactions between drugs and patient conditions, and refines treatment recommendations through iterative reasoning. It selects tools based on task objectives and executes structured function calls to solve therapeutic tasks that require clinical reasoning and cross-source validation. The ToolUniverse consolidates 211 tools from trusted sources, including all US FDA-approved drugs since 1939 and validated clinical insights from Open Targets. TxAgent outperforms leading LLMs, tool-use models, and reasoning agents across five new benchmarks: DrugPC, BrandPC, GenericPC, TreatmentPC, and DescriptionPC, covering 3,168 drug reasoning tasks and 456 personalized treatment scenarios. It achieves 92.1% accuracy in open-ended drug reasoning tasks, surpassing GPT-4o and outperforming DeepSeek-R1 (671B) in structured multi-step reasoning. TxAgent generalizes across drug name variants and descriptions. By integrating multi-step inference, real-time knowledge grounding, and tool-assisted decision-making, TxAgent ensures that treatment recommendations align with established clinical guidelines and real-world evidence, reducing the risk of adverse events and improving therapeutic decision-making.

📄 PDF Abstract BibTeX arXiv:2503.10970

Code (4)

mims-harvard/ToolUniverse 공식 구현
mims-harvard/TxAgent 공식 구현 pytorch
🤗 mims-harvard/ToolRAG-T1-GTE-Qwen2-1.5B 공식 구현
🤗 mims-harvard/TxAgent-T1-Llama-3.1-8B 공식 구현

Tasks

AI AgentDecision Making

Methods 이 논문이 사용한 방법론

ALIGN In the ALIGN method, visual and language representations are jointly trained from noisy image alt-text data. The image and text encoders are learned via contrastive loss…

Similar Papers 제목 키워드 기반

MedAI: Evaluating TxAgent's Therapeutic Agentic Reasoning in the NeurIPS CURE-Bench Competition

2025-12-12 · Tim Cofala, Christian Kalfar, Jingge Xiao, Johanna Schrader 외 arxiv

Therapeutic decision-making in clinical medicine constitutes a high-stakes domain in which AI guidance interacts with complex interactions among patient characteristics, disease processes, and pharmacological agents. Tas…

CureAgent: A Training-Free Executor-Analyst Framework for Clinical Reasoning

2025-12-05 · Ting-Ting Xie, Yixin Zhang arxiv

Current clinical agent built on small LLMs, such as TxAgent suffer from a \textit{Context Utilization Failure}, where models successfully retrieve biomedical evidence due to supervised finetuning but fail to ground their…

An AI agent for treatment reasoning over a biomedical tool universe

2026-06-27 · Shanghua Gao, Ayush Noori, Richard Zhu, Curtis Ginder 외 arxiv

Treatment reasoning underpins every therapeutic decision, integrating disease context, comorbidities, medications, contraindications, and evolving biomedical knowledge to select an appropriate therapy. It is inherently i…

Reinforcement Learning

TxGemma: Efficient and Agentic LLMs for Therapeutics

2025-04-08 · Eric Wang, Samuel Schmidgall, Paul F. Jaeger, Fan Zhang 외

Therapeutic development is a costly and high-risk endeavor that is often plagued by high failure rates. To address this, we introduce TxGemma, a suite of efficient, generalist large language models (LLMs) capable of ther…

Humanity's Last ExamProperty Prediction

Scalable Agentic Reasoning for Designing Biologics Targeting Intrinsically Disordered Proteins

2025-12-17 · Matthew Sinclair, Moeen Meigooni, Archit Vasan, Ozan Gokdemir 외 arxiv

Intrinsically disordered proteins (IDPs) represent crucial therapeutic targets due to their significant role in disease -- approximately 80\% of cancer-related proteins contain long disordered regions -- but their lack o…

Drug Discovery